{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:09:59Z","timestamp":1791608999210,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jaad.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T18:08:43Z","timestamp":1421172523000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?"],"prefix":"10.1016","volume":"72","author":[{"given":"Martine F.","family":"Raphael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corstiaan C.","family":"Breugem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florine A.E.","family":"Vlasveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn G.","family":"Slieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.M.A.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.P.J.","family":"Breur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.12.019_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-3016.2011.01214.x","article-title":"The prevalence and risk factors in infantile hemangiomas: a case-control study in the Dutch population","volume":"26","author":"Hoornweg","year":"2012","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jaad.2014.12.019_bib2","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.12.019_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the\u00a0treatment of hemangiomas: a case series of 28 infants","volume":"65","author":"De Graaf","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.12.019_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2010.11.056","article-title":"Atenolol: a promising alternative to propranolol for the treatment of hemangiomas","volume":"65","author":"Raphael","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.12.019_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bjps.2013.07.035","article-title":"Treatment of infantile hemangiomas with atenolol: comparison with a historical propranolol group","volume":"66","author":"de Graaf","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2014.12.019_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2014.12.019_bib7","series-title":"Nelson textbook of pediatrics","article-title":"Chapter 62: Pediatric emergencies and resuscitation. Table 62-1: Vital signs at various ages","author":"Hartman","year":"2011"},{"key":"10.1016\/j.jaad.2014.12.019_bib8","series-title":"Maternal-child nursing","first-page":"1624","article-title":"Normal blood pressure readings adapted from Second Task Force on Blood Pressure Control in Children, National Heart, Lung, and Blood Institute, Bethesda, 1987","author":"Rosner","year":"2000"},{"key":"10.1016\/j.jaad.2014.12.019_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2010.01224.x","article-title":"Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report","volume":"28","author":"Breur","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2014.12.019_bib10","first-page":"85","article-title":"Congenital complete heart block an international study of the natural history story","volume":"4","author":"Michaelsson","year":"1972","journal-title":"Cardiovasc Clin"},{"key":"10.1016\/j.jaad.2014.12.019_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bjsm.2009.064394","article-title":"The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009","volume":"43","author":"Ljungqvist","year":"2009","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jaad.2014.12.019_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.HYP.5.6.852","article-title":"Time course of development of the antihypertensive effect of propranolol","volume":"5","author":"Fagan","year":"1983","journal-title":"Hypertension"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214023044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214023044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:33:20Z","timestamp":1759271600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214023044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0190962214023044"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.12.019","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}